Results

Total Results: over 10,000 records

Showing results for "drugs".

401. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/epilepsy-medicine/research-protocol
     December 01, 2019 - Antiepileptic Drugs . Fourth ed. New York, Raven Press; 1995. p. 799-806. … Antiepileptic Drugs . Philadelphia, Lippincott Williams & Wilkins; 2002. p. 901-5. … Therapeutic equivalence of generic drugs letter to health practitioners. … drugs, generic/ therapeutic equivalency/ (brand adj name).mp. … drugs, generic/ therapeutic equivalency/ (brand adj name).mp.

402. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors - 2012 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-substitution-errors/annual-summary/2012
     January 01, 2012 - The Delphi process identified the drugs that the participants thought to be of high potential patient … team used a Food and Drug Administration (FDA) file that cross-referenced the brand name and generic drugs … drug pairs included in the final round of the Delphi process did not have a person who received both drugs … errors for these pairs is feasible in the pharmacy setting, so any patient who receives both of these drugs … For 505 pairs (83 percent), the cumulative total of subjects who received both drugs in a pair was 3,610

403. Public Comment on Draft Research Plan: Interventions to Reduce the Nonmedical Use of Drugs in Children and Adolescents | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-interventions-reduce-nonmedical-use-drugs-children-and-adolescents
     February 11, 2013 - Public Comment on Draft Research Plan: Interventions to Reduce the Nonmedical Use of Drugs in Children … posted for public comment its draft Research Plan on interventions to reduce the nonmedical use of drugs

404. Implementation of rules based computerised bedside prescribing and administration: intervention study | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/implementation-rules-based
     March 18, 2021 - prescribing system with the aim of improving the safety of prescriptions and the administration of drugs … Intervention:  A rules based system for prescribing and recording the administration of drugs which was … computerized prescribing system with the aim of improving the safety of prescriptions and administration of drugs

405. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

406. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.innovations.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

407. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

408. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

409. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.talkingquality.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

410. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.healthcare411.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

411. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.cpsi.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

412. Final Research Plan: Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
     August 30, 2018 - stated aim of the study but is a reported outcome Condition Any use of psychoactive illicit drugs … drugs (e.g., anabolic steroids, laxatives, aspirin) Population Children, adolescents … , and young adults (age ≤25 years), including pregnant females, who do not regularly use illicit drugs … adolescent, young adult), sex, race/ethnicity   Young persons who regularly use illicit drugs … in children, adolescents, and young adults who are nonusers or who have used illicit and nonmedical drugs

413. Medical Expenditure Panel Survey Publication Details
     meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=937
     December 10, 2009 - Search MEPS S M L XL   Publication Details Title:    Trends in Outpatient Prescription Thyroid Drugs … Household Component Publication date:    December 10, 2009 Description:    For prescription thyroid drugs … Total prescribed medicine purchases of prescription thyroid drugs by adults rose from 45.3 million prescription … : Agency for Healthcare Research and Quality Source:    Web Only MEPS Topics:    Prescription Drugs

414. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/35117/psn-pdf
     June 22, 2009 - procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs … procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs … They conclude that all patients receiving these drugs are at risk for adverse events.

415. STATISTICAL BRIEF #43: Outpatient Prescription Medicines: A Comparison of Expenditures by Household-Reported Condition, 1987 and 2001
     meps.ahrq.gov/data_files/publications/st43/stat43.shtml
     July 01, 2004 - July 2004 Marie Stagnitti, MPA and Mamatha Pancholi, MS Highlights Prescribed drugs … Total annual expenditures for prescribed drugs reported by households to treat mental health conditions … In 1987, prescribed drugs reported as purchased to treat mental heath disorders ranked sixth in total … In 2001, prescription drugs reported as purchased to treat arthritis fell to eighth in the ranking of … Prescribed drugs reported as purchased to treat high blood pressure ranked highest in terms of total

416. STATISTICAL BRIEF #43: Outpatient Prescription Medicines: A Comparison of Expenditures by Household-Reported Condition, 1987 and 2001
     meps.ahrq.gov/data_files/publications/st43/draft/stat43.shtml
     July 01, 2004 - July 2004 Marie Stagnitti, MPA and Mamatha Pancholi, MS Highlights Prescribed drugs … Total annual expenditures for prescribed drugs reported by households to treat mental health conditions … In 1987, prescribed drugs reported as purchased to treat mental heath disorders ranked sixth in total … In 2001, prescription drugs reported as purchased to treat arthritis fell to eighth in the ranking of … Prescribed drugs reported as purchased to treat high blood pressure ranked highest in terms of total

417. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/846169/psn-pdf
     March 15, 2023 - Distraction of the Anesthesiologist and Lack of Resuscitation Drugs Resulting in Delayed Treatment of … Distraction of the Anesthesiologist and Lack of Resuscitation Drugs Resulting in Delayed Treatment of … https://psnet.ahrq.gov/web-mm/distraction-anesthesiologist-and-lack-resuscitation-drugs-resulting-delayed … The anesthesiologist was distracted briefly by the anesthesia technologist to sign for opioid drugs … However, the drug refrigerator was broken and contained no drugs.

418. S96 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - Of 10,383 reports in 2004, 100% listed patient age, sex, and disposition; 98% listed the implicated drugs … provides detailed and timely infor- mation on outpatient ADEs treated in EDs and identifies specific drugs … Deiden- tified data are then forwarded to CDC where all case reports involving pharmaceutical products … drugs are suspected, this information may be added as a free-text description. … Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

419. S96 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - Of 10,383 reports in 2004, 100% listed patient age, sex, and disposition; 98% listed the implicated drugs … provides detailed and timely infor- mation on outpatient ADEs treated in EDs and identifies specific drugs … Deiden- tified data are then forwarded to CDC where all case reports involving pharmaceutical products … drugs are suspected, this information may be added as a free-text description. … Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

420. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
     January 01, 2008 - manic or depressive phases, rapid cycling, mixed states), do the typical and atypical antipsychotic drugs … For adults experiencing a first episode of schizophrenia, do the atypical antipsychotic drugs differ … comparative evidence that differences in adherence or persistence among the atypical antipsychotic drugs … developmental disorders or disruptive behavior disorders, do the typical and atypical antipsychotic drugs … Behavioral and Psychological Symptoms of Dementia (BPSD), do the typical and atypical antipsychotic drugs